About Dr. Omer Fatih Olmez
Prof. Dr. Omer Fatih Olmez is a senior Medical Oncologist and academician with over 23 years of clinical experience in systemic cancer therapy, including chemotherapy, targeted therapy and immunotherapy. He is internationally recognised for his work in lung cancer, breast cancer, gastrointestinal cancers and haematologic malignancies, making him a sought-after Omer Fatih Olmez Medical Oncologist consultant for international patients.
- 23+ years of clinical experience in medical oncology
- Earned full Professorship in Medical Oncology in 2019
- Author of 25+ international publications, 35 papers, 9 national publications and 5 international proceedings
- Member of ESMO, ASCO and the Turkish Medical Oncology Society
- Special interests: lung cancer, breast cancer, gastrointestinal & haematologic cancers
Qualifications & Credentials
Medical Degrees
- MD (Faculty of Medicine) — Ondokuz Mayıs University, Samsun, Turkey, 2001
- Specialization in Internal Medicine — Uludağ University Faculty of Medicine, Bursa, Turkey, 2009
- Subspecialty / Fellowship in Medical Oncology — Uludağ University Faculty of Medicine, Bursa, Turkey, 2012
Fellowships & Special Training
- Medical Oncology Fellowship — Uludağ University, Bursa, Turkey, 2012
- Associate Professor (Doçent) academic title, 2013
- Full Professor (Profesör) academic title, 2019
Certifications & Accreditations
- Turkish Medical Council Registration
- European Society for Medical Oncology (ESMO) — Member
- American Society of Clinical Oncology (ASCO) — Member
- Turkish Medical Oncology Society — Member
Areas of Expertise
Major Conditions Treated
- Lung Cancer (NSCLC & SCLC)
- Breast Cancer
- Gastrointestinal Cancers (Stomach, Colorectal, Pancreatic, Liver)
- Haematologic Malignancies (Lymphoma, Leukaemia, Multiple Myeloma)
- Genitourinary Cancers (Prostate, Bladder, Kidney)
- Head & Neck Cancers
- Gynaecologic Cancers
- Sarcomas & Rare Tumours
Sub-specialties
- Targeted & Precision Oncology: Personalised therapy based on molecular profiling — a leading focus for the best Medical Oncologist Istanbul, Turkey patients seek for advanced cancer care.
- Immunotherapy: Expert use of checkpoint inhibitors (PD-1/PD-L1, CTLA-4) in NSCLC, melanoma and bladder cancer.
- Multidisciplinary Tumour Board Care: Coordinated treatment planning with surgical and radiation oncology — particularly valuable for international second-opinion cases.
Advanced Procedures & Treatments
- Chemotherapy (IV & oral regimens)
- Targeted Therapy (EGFR, ALK, HER2, BRAF, KRAS inhibitors)
- Immunotherapy / Checkpoint Inhibitors
- Hormone Therapy (Breast, Prostate Cancer)
- Tumour Marker Monitoring & Molecular Profiling
- Clinical Trial Enrolment
- Palliative & Supportive Oncology Care
List of Disease and Treatment for which Dr. Omer Fatih Olmez can be consulted
Professional Experience
Current Affiliation
- Acıbadem Maslak Hospital, Istanbul — Professor, Department of Medical Oncology, 2025–Present
Past Affiliations
- Medipol Mega University Hospital, Istanbul — Professor of Medical Oncology, until 2025
- Ali Osman Sönmez Oncology Hospital, Bursa — Medical Oncologist, 2013–2014
- Uludağ University Faculty of Medicine, Bursa — Medical Oncology Fellow / Specialist, 2009–2013
Academic & Research Roles
- Professor of Medical Oncology, Istanbul Medipol University (until 2025)
- Active investigator in multicentre national and international oncology trials
Key Achievements
- 23+ years of clinical experience in medical oncology
- 25 international publications, 9 national publications, 35 papers and 5 international proceedings
- Achieved Professorship in 2019
- Extensive international patient practice, including Gulf, CIS, African and South Asian patients
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
- Turkish Medical Oncology Society
- Turkish Medical Association
Research & Publications
Published Papers (Selected)
- Olmez OF, et al. "Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy." Multicentre study, peer-reviewed publication.
- Olmez OF, et al. "Immune Checkpoint Blockade Therapies Efficacy and Toxicity in Patients With Impaired Renal Function in Metastatic Bladder Cancer."
- Olmez OF, et al. "Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?"
- Avcı N, Kurt E, Kazak E, Alkış N, Çubukçu E, Ölmez ÖF, et al. "Association and Prognostic Significance of the Functional −1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer."
Ongoing Research & Clinical Interests
- Immunotherapy outcomes in solid tumours
- Targeted therapy in lung and breast cancer
- Tumour-infiltrating lymphocytes (TILs) and chemo-immunotherapy response
- Molecular profiling and precision oncology
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Medical Oncology Consultation | ₹4,000 – ₹8,000 | $50 – $100 |
| Chemotherapy (per cycle, regimen-dependent) | ₹40,000 – ₹2,50,000 | $500 – $3,000 |
| Targeted Therapy (per month, drug-dependent) | ₹1,50,000 – ₹6,00,000 | $1,800 – $7,200 |
| Immunotherapy (per cycle) | ₹2,00,000 – ₹5,50,000 | $2,400 – $6,600 |
| Molecular Profiling / NGS Panel | ₹40,000 – ₹2,00,000 | $500 – $2,400 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. Omer Fatih Olmez use in Medical Oncologist treatment?
Prof. Dr. Omer Fatih Olmez uses precision-medicine tools including next-generation sequencing (NGS), molecular tumour profiling, immunotherapy with checkpoint inhibitors (PD-1/PD-L1) and modern targeted therapies (EGFR, ALK, HER2 inhibitors). He also participates in international clinical trials, giving patients access to emerging treatments before they are widely available.
2. What conditions does Prof. Dr. Omer Fatih Olmez specialize in treating?
As a leading Medical Oncologist specialist Istanbul, Turkey, he treats lung cancer (NSCLC and small-cell), breast cancer, gastrointestinal cancers (stomach, colorectal, pancreatic, liver), genitourinary tumours, head & neck cancers and haematologic malignancies. International patients also consult him for second opinions on advanced and rare tumours.
3. How do I book an appointment with Prof. Dr. Omer Fatih Olmez?
Appointments with Prof. Dr. Omer Fatih Olmez can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. Omer Fatih Olmez?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. Omer Fatih Olmez, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. Dr. Omer Fatih Olmez offer second opinions for Medical Oncologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Medical Oncologist specialist in Istanbul, Turkey.


















